Capital Planning Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,159
| Closed | -$329K | – | 138 |
|
|
2022
Q1 | $329K | Sell |
7,159
-196,617
| -96% | -$9.04M | 0.07% | 122 |
|
|
2021
Q4 | $12.5M | Sell |
203,776
-14,896
| -7% | -$912K | 2.38% | 9 |
|
|
2021
Q3 | $16.3M | Buy |
218,672
+3,225
| +1% | +$241K | 3.39% | 6 |
|
|
2021
Q2 | $19.9M | Buy |
215,447
+11,150
| +5% | +$1.03M | 4.09% | 4 |
|
|
2021
Q1 | $18.1M | Buy |
204,297
+23,587
| +13% | +$2.09M | 4.06% | 4 |
|
|
2020
Q4 | $16.9M | Buy |
180,710
+9,669
| +6% | +$902K | 4.14% | 4 |
|
|
2020
Q3 | $10.9M | Buy |
171,041
+9,445
| +6% | +$602K | 2.99% | 8 |
|
|
2020
Q2 | $8.43M | Buy |
161,596
+17,207
| +12% | +$898K | 2.51% | 10 |
|
|
2020
Q1 | $4.52M | Buy |
+144,389
| New | +$4.52M | 1.69% | 17 |
|